Entest Group Inc

[JokersWild12]

We know that they have had discussions though with large biopharma companies already and interest has been expressed in their tech. CEO stated they are in the right pond with $1 Bil acquisition prices. That was some time ago before the more significant breakthroughs in their testing, which with every pass at ChemDiv looks to yield better potency, less toxicity and a wider application for the drug use for both human and animal cancer and autoimmune disease. The former Petco CEO will have wide breadth of connections and credibility to the company. This will help with future funding or purchase. All IMO. GL.